Treatment of Pkd1+/+ metanephroi with increasing SKA-111 concentrations led to dose-dependent cystogenesis and > 2-fold increased percentage of cyst area (cystic index) (Figure 2, B and C). The gene discussed is PKD1; the disease is cyst.